nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—type 2 diabetes mellitus—polycystic ovary syndrome	0.607	1	CtDrD
Gliclazide—VEGFA—polycystic ovary syndrome	0.303	1	CbGaD
Gliclazide—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.00216	0.0779	CcSEcCtD
Gliclazide—CYP2C19—urine—polycystic ovary syndrome	0.00208	0.107	CbGeAlD
Gliclazide—CYP2C9—urine—polycystic ovary syndrome	0.00162	0.0829	CbGeAlD
Gliclazide—VEGFA—adrenal cortex—polycystic ovary syndrome	0.00145	0.0746	CbGeAlD
Gliclazide—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.00137	0.0494	CcSEcCtD
Gliclazide—VEGFA—endometrium—polycystic ovary syndrome	0.0013	0.0666	CbGeAlD
Gliclazide—VEGFA—uterus—polycystic ovary syndrome	0.0012	0.0614	CbGeAlD
Gliclazide—Toothache—Metformin—polycystic ovary syndrome	0.00118	0.0427	CcSEcCtD
Gliclazide—VEGFA—pituitary gland—polycystic ovary syndrome	0.00117	0.0603	CbGeAlD
Gliclazide—VEGFA—adipose tissue—polycystic ovary syndrome	0.00117	0.06	CbGeAlD
Gliclazide—Nail disorder—Metformin—polycystic ovary syndrome	0.00111	0.0401	CcSEcCtD
Gliclazide—Upset stomach—Metformin—polycystic ovary syndrome	0.0011	0.0397	CcSEcCtD
Gliclazide—VEGFA—adrenal gland—polycystic ovary syndrome	0.00105	0.0538	CbGeAlD
Gliclazide—Heartburn—Metformin—polycystic ovary syndrome	0.00105	0.0378	CcSEcCtD
Gliclazide—VEGFA—female gonad—polycystic ovary syndrome	0.000978	0.0502	CbGeAlD
Gliclazide—VEGFA—vagina—polycystic ovary syndrome	0.000972	0.0499	CbGeAlD
Gliclazide—Fungal infection—Metformin—polycystic ovary syndrome	0.000932	0.0337	CcSEcCtD
Gliclazide—Blood disorder—Metformin—polycystic ovary syndrome	0.000862	0.0311	CcSEcCtD
Gliclazide—ABCC8—endometrium—polycystic ovary syndrome	0.000855	0.0439	CbGeAlD
Gliclazide—ABCC8—pituitary gland—polycystic ovary syndrome	0.000774	0.0397	CbGeAlD
Gliclazide—KCNJ11—adrenal gland—polycystic ovary syndrome	0.00075	0.0385	CbGeAlD
Gliclazide—KCNJ11—female gonad—polycystic ovary syndrome	0.0007	0.0359	CbGeAlD
Gliclazide—ABCC8—adrenal gland—polycystic ovary syndrome	0.000691	0.0355	CbGeAlD
Gliclazide—Neuropathy—Metformin—polycystic ovary syndrome	0.000676	0.0244	CcSEcCtD
Gliclazide—KCNJ11—endocrine gland—polycystic ovary syndrome	0.000651	0.0334	CbGeAlD
Gliclazide—ABCC8—endocrine gland—polycystic ovary syndrome	0.000599	0.0308	CbGeAlD
Gliclazide—Injury—Metformin—polycystic ovary syndrome	0.000568	0.0205	CcSEcCtD
Gliclazide—Renal impairment—Metformin—polycystic ovary syndrome	0.000549	0.0198	CcSEcCtD
Gliclazide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000535	0.0193	CcSEcCtD
Gliclazide—Pain in extremity—Metformin—polycystic ovary syndrome	0.000523	0.0189	CcSEcCtD
Gliclazide—ALB—adrenal gland—polycystic ovary syndrome	0.000495	0.0254	CbGeAlD
Gliclazide—Abdominal distension—Metformin—polycystic ovary syndrome	0.000455	0.0164	CcSEcCtD
Gliclazide—Angina pectoris—Metformin—polycystic ovary syndrome	0.00044	0.0159	CcSEcCtD
Gliclazide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000433	0.0156	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00042	0.0152	CcSEcCtD
Gliclazide—Drowsiness—Metformin—polycystic ovary syndrome	0.000403	0.0145	CcSEcCtD
Gliclazide—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000395	0.0143	CcSEcCtD
Gliclazide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000381	0.0138	CcSEcCtD
Gliclazide—CYP2C19—vagina—polycystic ovary syndrome	0.000369	0.019	CbGeAlD
Gliclazide—Bradycardia—Metformin—polycystic ovary syndrome	0.000368	0.0133	CcSEcCtD
Gliclazide—Rhinitis—Metformin—polycystic ovary syndrome	0.000362	0.0131	CcSEcCtD
Gliclazide—Hepatitis—Metformin—polycystic ovary syndrome	0.000361	0.0131	CcSEcCtD
Gliclazide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00036	0.013	CcSEcCtD
Gliclazide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000356	0.0129	CcSEcCtD
Gliclazide—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000346	0.0177	CbGeAlD
Gliclazide—Eye disorder—Metformin—polycystic ovary syndrome	0.000338	0.0122	CcSEcCtD
Gliclazide—Flushing—Metformin—polycystic ovary syndrome	0.000335	0.0121	CcSEcCtD
Gliclazide—Chills—Metformin—polycystic ovary syndrome	0.000324	0.0117	CcSEcCtD
Gliclazide—Malnutrition—Metformin—polycystic ovary syndrome	0.000315	0.0114	CcSEcCtD
Gliclazide—Erythema—Metformin—polycystic ovary syndrome	0.000315	0.0114	CcSEcCtD
Gliclazide—Flatulence—Metformin—polycystic ovary syndrome	0.00031	0.0112	CcSEcCtD
Gliclazide—Glipizide—PPARG—polycystic ovary syndrome	0.000302	1	CrCbGaD
Gliclazide—Tremor—Metformin—polycystic ovary syndrome	0.000295	0.0106	CcSEcCtD
Gliclazide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000292	0.0105	CcSEcCtD
Gliclazide—Malaise—Metformin—polycystic ovary syndrome	0.000284	0.0102	CcSEcCtD
Gliclazide—Palpitations—Metformin—polycystic ovary syndrome	0.000278	0.01	CcSEcCtD
Gliclazide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000277	0.00999	CcSEcCtD
Gliclazide—Hypertension—Metformin—polycystic ovary syndrome	0.000272	0.00981	CcSEcCtD
Gliclazide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000268	0.0137	CbGeAlD
Gliclazide—Chest pain—Metformin—polycystic ovary syndrome	0.000268	0.00967	CcSEcCtD
Gliclazide—Myalgia—Metformin—polycystic ovary syndrome	0.000268	0.00967	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000266	0.00961	CcSEcCtD
Gliclazide—Discomfort—Metformin—polycystic ovary syndrome	0.000265	0.00956	CcSEcCtD
Gliclazide—Infection—Metformin—polycystic ovary syndrome	0.000255	0.00921	CcSEcCtD
Gliclazide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000252	0.0091	CcSEcCtD
Gliclazide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000251	0.00908	CcSEcCtD
Gliclazide—Skin disorder—Metformin—polycystic ovary syndrome	0.000249	0.00901	CcSEcCtD
Gliclazide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000248	0.00897	CcSEcCtD
Gliclazide—Hypotension—Metformin—polycystic ovary syndrome	0.00024	0.00867	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000234	0.00845	CcSEcCtD
Gliclazide—Paraesthesia—Metformin—polycystic ovary syndrome	0.000231	0.00833	CcSEcCtD
Gliclazide—Dyspnoea—Metformin—polycystic ovary syndrome	0.000229	0.00827	CcSEcCtD
Gliclazide—Somnolence—Metformin—polycystic ovary syndrome	0.000228	0.00824	CcSEcCtD
Gliclazide—Dyspepsia—Metformin—polycystic ovary syndrome	0.000226	0.00816	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000222	0.00801	CcSEcCtD
Gliclazide—Fatigue—Metformin—polycystic ovary syndrome	0.000221	0.008	CcSEcCtD
Gliclazide—Constipation—Metformin—polycystic ovary syndrome	0.00022	0.00793	CcSEcCtD
Gliclazide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000212	0.00764	CcSEcCtD
Gliclazide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00021	0.00758	CcSEcCtD
Gliclazide—Urticaria—Metformin—polycystic ovary syndrome	0.000204	0.00737	CcSEcCtD
Gliclazide—Abdominal pain—Metformin—polycystic ovary syndrome	0.000203	0.00733	CcSEcCtD
Gliclazide—Asthenia—Metformin—polycystic ovary syndrome	0.000184	0.00665	CcSEcCtD
Gliclazide—Pruritus—Metformin—polycystic ovary syndrome	0.000182	0.00656	CcSEcCtD
Gliclazide—Diarrhoea—Metformin—polycystic ovary syndrome	0.000176	0.00635	CcSEcCtD
Gliclazide—Dizziness—Metformin—polycystic ovary syndrome	0.00017	0.00613	CcSEcCtD
Gliclazide—Vomiting—Metformin—polycystic ovary syndrome	0.000163	0.0059	CcSEcCtD
Gliclazide—Rash—Metformin—polycystic ovary syndrome	0.000162	0.00585	CcSEcCtD
Gliclazide—Dermatitis—Metformin—polycystic ovary syndrome	0.000162	0.00584	CcSEcCtD
Gliclazide—Headache—Metformin—polycystic ovary syndrome	0.000161	0.00581	CcSEcCtD
Gliclazide—Nausea—Metformin—polycystic ovary syndrome	0.000153	0.00551	CcSEcCtD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	2.59e-05	0.000606	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FSHR—polycystic ovary syndrome	2.58e-05	0.000606	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.58e-05	0.000604	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SULT2A1—polycystic ovary syndrome	2.56e-05	0.000601	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.54e-05	0.000596	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	2.53e-05	0.000593	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.52e-05	0.000591	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	2.49e-05	0.000583	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SULT2A1—polycystic ovary syndrome	2.49e-05	0.000582	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—RRM2—polycystic ovary syndrome	2.48e-05	0.000582	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	2.47e-05	0.000578	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.43e-05	0.000569	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—RRM2—polycystic ovary syndrome	2.41e-05	0.000564	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	2.41e-05	0.000564	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—YAP1—polycystic ovary syndrome	2.39e-05	0.000561	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.36e-05	0.000554	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	2.36e-05	0.000552	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—PPARG—polycystic ovary syndrome	2.34e-05	0.000548	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	2.34e-05	0.000547	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—YAP1—polycystic ovary syndrome	2.32e-05	0.000544	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FST—polycystic ovary syndrome	2.3e-05	0.00054	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NAMPT—polycystic ovary syndrome	2.3e-05	0.000539	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—INS—polycystic ovary syndrome	2.29e-05	0.000537	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.28e-05	0.000534	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.28e-05	0.000533	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP11A1—polycystic ovary syndrome	2.27e-05	0.000532	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	2.25e-05	0.000527	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LHB—polycystic ovary syndrome	2.25e-05	0.000527	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.25e-05	0.000527	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	2.23e-05	0.000523	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NAMPT—polycystic ovary syndrome	2.23e-05	0.000522	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—AKT2—polycystic ovary syndrome	2.22e-05	0.000519	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP11A1—polycystic ovary syndrome	2.2e-05	0.000516	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.2e-05	0.000515	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	2.19e-05	0.000514	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IGF1—polycystic ovary syndrome	2.18e-05	0.00051	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	2.18e-05	0.00051	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—AKT2—polycystic ovary syndrome	2.18e-05	0.00051	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKR1C3—polycystic ovary syndrome	2.14e-05	0.000502	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.13e-05	0.000499	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.13e-05	0.000499	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP17A1—polycystic ovary syndrome	2.11e-05	0.000495	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SCT—polycystic ovary syndrome	2.11e-05	0.000494	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	2.1e-05	0.000491	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	2.09e-05	0.00049	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.08e-05	0.000488	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKR1C3—polycystic ovary syndrome	2.08e-05	0.000487	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.08e-05	0.000487	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SERPINE1—polycystic ovary syndrome	2.07e-05	0.000484	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.05e-05	0.00048	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP17A1—polycystic ovary syndrome	2.05e-05	0.00048	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SUOX—polycystic ovary syndrome	2.04e-05	0.000479	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	2.04e-05	0.000479	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.02e-05	0.000473	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.01e-05	0.000471	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	2.01e-05	0.00047	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGF18—polycystic ovary syndrome	1.98e-05	0.000463	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RBP4—polycystic ovary syndrome	1.96e-05	0.000459	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.91e-05	0.000448	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	1.91e-05	0.000448	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	1.9e-05	0.000445	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.87e-05	0.000438	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.86e-05	0.000435	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	1.83e-05	0.00043	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	1.83e-05	0.00043	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—YAP1—polycystic ovary syndrome	1.83e-05	0.000428	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	1.83e-05	0.000428	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—TH—polycystic ovary syndrome	1.83e-05	0.000428	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.81e-05	0.000424	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GAB1—polycystic ovary syndrome	1.8e-05	0.000423	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SLC2A4—polycystic ovary syndrome	1.78e-05	0.000416	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—TH—polycystic ovary syndrome	1.77e-05	0.000415	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	1.77e-05	0.000415	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.74e-05	0.000409	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.73e-05	0.000406	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INSR—polycystic ovary syndrome	1.72e-05	0.000404	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC2A4—polycystic ovary syndrome	1.72e-05	0.000404	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	1.71e-05	0.000399	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.7e-05	0.000399	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	1.7e-05	0.000398	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	1.67e-05	0.000392	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	1.67e-05	0.000392	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP19A1—polycystic ovary syndrome	1.67e-05	0.000391	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.67e-05	0.00039	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—polycystic ovary syndrome	1.65e-05	0.000388	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.65e-05	0.000387	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.64e-05	0.000385	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.64e-05	0.000384	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP19A1—polycystic ovary syndrome	1.62e-05	0.00038	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	1.62e-05	0.000378	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TEAD2—polycystic ovary syndrome	1.62e-05	0.000378	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.61e-05	0.000378	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PGR—polycystic ovary syndrome	1.6e-05	0.000374	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.56e-05	0.000364	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	1.55e-05	0.000364	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.55e-05	0.000364	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	1.55e-05	0.000363	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLAT—polycystic ovary syndrome	1.55e-05	0.000362	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.53e-05	0.000358	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.52e-05	0.000356	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GNAS—polycystic ovary syndrome	1.49e-05	0.000349	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	1.49e-05	0.000349	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	1.49e-05	0.000349	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GHRL—polycystic ovary syndrome	1.48e-05	0.000348	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PLAT—polycystic ovary syndrome	1.48e-05	0.000348	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.48e-05	0.000346	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	1.45e-05	0.00034	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	1.45e-05	0.00034	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GNAS—polycystic ovary syndrome	1.45e-05	0.000339	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.44e-05	0.000337	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NCOR1—polycystic ovary syndrome	1.42e-05	0.000333	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.42e-05	0.000332	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ATF1—polycystic ovary syndrome	1.42e-05	0.000332	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	1.42e-05	0.000332	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	1.41e-05	0.000329	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—polycystic ovary syndrome	1.4e-05	0.000329	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.39e-05	0.000327	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.38e-05	0.000324	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	1.38e-05	0.000323	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.37e-05	0.000321	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	1.35e-05	0.000317	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP1A1—polycystic ovary syndrome	1.35e-05	0.000316	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.35e-05	0.000315	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.34e-05	0.000313	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	1.32e-05	0.00031	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	1.32e-05	0.00031	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NGFR—polycystic ovary syndrome	1.31e-05	0.000306	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	1.31e-05	0.000306	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PRL—polycystic ovary syndrome	1.3e-05	0.000303	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	1.28e-05	0.000301	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.27e-05	0.000298	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—polycystic ovary syndrome	1.26e-05	0.000294	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.25e-05	0.000293	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.23e-05	0.000288	CbGpPWpGaD
Gliclazide—ALB—Metabolism—STAR—polycystic ovary syndrome	1.22e-05	0.000287	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.22e-05	0.000287	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	1.22e-05	0.000285	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	1.21e-05	0.000285	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.21e-05	0.000283	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GNAS—polycystic ovary syndrome	1.19e-05	0.000278	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	1.15e-05	0.00027	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNAS—polycystic ovary syndrome	1.14e-05	0.000267	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.11e-05	0.00026	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	1.1e-05	0.000257	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMMR—polycystic ovary syndrome	1.09e-05	0.000256	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.09e-05	0.000254	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.09e-05	0.000254	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NRG1—polycystic ovary syndrome	1.07e-05	0.00025	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1.05e-05	0.000246	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	1.04e-05	0.000244	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.03e-05	0.000241	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.03e-05	0.000241	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARG—polycystic ovary syndrome	1.02e-05	0.000239	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—POMC—polycystic ovary syndrome	1e-05	0.000235	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—polycystic ovary syndrome	1e-05	0.000235	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	1e-05	0.000235	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—INS—polycystic ovary syndrome	9.99e-06	0.000234	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.9e-06	0.000232	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	9.87e-06	0.000231	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	9.79e-06	0.000229	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.75e-06	0.000228	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	9.74e-06	0.000228	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	9.73e-06	0.000228	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—INS—polycystic ovary syndrome	9.68e-06	0.000227	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LHB—polycystic ovary syndrome	9.49e-06	0.000222	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	9.34e-06	0.000219	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	9.28e-06	0.000217	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.23e-06	0.000216	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRS2—polycystic ovary syndrome	9.13e-06	0.000214	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	8.98e-06	0.00021	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—polycystic ovary syndrome	8.93e-06	0.000209	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.93e-06	0.000209	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.75e-06	0.000205	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	8.52e-06	0.0002	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.52e-06	0.0002	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.42e-06	0.000197	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	8.33e-06	0.000195	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	8.27e-06	0.000194	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	8.06e-06	0.000189	CbGpPWpGaD
Gliclazide—ALB—Metabolism—RRM2—polycystic ovary syndrome	8.01e-06	0.000188	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.98e-06	0.000187	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRS1—polycystic ovary syndrome	7.97e-06	0.000187	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.77e-06	0.000182	CbGpPWpGaD
Gliclazide—ALB—Metabolism—YAP1—polycystic ovary syndrome	7.72e-06	0.000181	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—polycystic ovary syndrome	7.68e-06	0.00018	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT2—polycystic ovary syndrome	7.68e-06	0.00018	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—polycystic ovary syndrome	7.67e-06	0.00018	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—polycystic ovary syndrome	7.63e-06	0.000179	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.59e-06	0.000178	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	7.42e-06	0.000174	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NAMPT—polycystic ovary syndrome	7.42e-06	0.000174	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—polycystic ovary syndrome	7.38e-06	0.000173	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT2—polycystic ovary syndrome	7.37e-06	0.000173	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.37e-06	0.000173	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.35e-06	0.000172	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	7.32e-06	0.000172	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	7.3e-06	0.000171	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.27e-06	0.00017	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	7.19e-06	0.000168	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.01e-06	0.000164	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	6.93e-06	0.000162	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	6.92e-06	0.000162	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	6.81e-06	0.000159	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.77e-06	0.000159	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	6.66e-06	0.000156	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.62e-06	0.000155	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	6.57e-06	0.000154	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.55e-06	0.000154	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.53e-06	0.000153	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.32e-06	0.000148	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	6.21e-06	0.000145	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	6.11e-06	0.000143	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	6.07e-06	0.000142	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.03e-06	0.000141	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.99e-06	0.00014	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.95e-06	0.000139	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TH—polycystic ovary syndrome	5.89e-06	0.000138	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	5.73e-06	0.000134	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.66e-06	0.000133	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.57e-06	0.000131	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	5.39e-06	0.000126	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TH—polycystic ovary syndrome	5.29e-06	0.000124	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	5.14e-06	0.000121	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	5.02e-06	0.000118	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.84e-06	0.000113	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.82e-06	0.000113	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GNAS—polycystic ovary syndrome	4.81e-06	0.000113	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.69e-06	0.00011	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NCOR1—polycystic ovary syndrome	4.58e-06	0.000107	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.41e-06	0.000103	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	4.34e-06	0.000102	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	4.32e-06	0.000101	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	4.11e-06	9.63e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—polycystic ovary syndrome	4.05e-06	9.48e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.94e-06	9.22e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.9e-06	9.13e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.75e-06	8.78e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.63e-06	8.51e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.55e-06	8.33e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—polycystic ovary syndrome	3.33e-06	7.81e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.31e-06	7.76e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—polycystic ovary syndrome	3.28e-06	7.69e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—polycystic ovary syndrome	3.24e-06	7.59e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—polycystic ovary syndrome	3.22e-06	7.54e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.95e-06	6.9e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.91e-06	6.81e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.89e-06	6.77e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.69e-06	6.3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.65e-06	6.21e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.64e-06	6.17e-05	CbGpPWpGaD
